Grundfos India Extends Help to Migrant Workers and Underprivileged during COVID-19 pandemic

The ongoing Coronavirus pandemic has created unprecedented health and humanitarian crisis. Grundfos India, a global leader in pump solutions and water technology is helping the vulnerable communities and government hospitals.

With the outbreak of COVID-19 resulting in the national lockdown, many migrants and underprivileged communities have been struggling to get food. With the help of its NGO partners, Grundfos India has provided food kits to more than 3000 people in Chennai. 

 Additionally, the company has donated funds that will go towards procuring key medical and protective equipment for government hospitals, including ventilators, surgical masks, CVN95+ mask, protective goggles, and nitrile gloves.

Saravanan Panneer Selvam, General Manager, Grundfos India, said, “We all are going through some unprecedented times and everyone must contribute in any way possible. Grundfos India has been working closely with local authorities to provide food kits to the migrant workers housed close to our facility in Chennai. We are also donating towards various other food distribution efforts in the city. We realize the critical support that our healthcare and medical staff require and have donated funds that will go towards equipping them in this fight against COVID-19.”

 Grundfos’ production facility in Bjerringbro, Denmark is delivering up to 5000 visors or face shields a day to aid frontline health workers in the fight against coronavirus. The delivery of these visors also includes other countries in areas, where Grundfos has production facilities. A key factor in developing the visor was making it easy to manufacture and convenient for medical staff to use. The mask consists of a normal sheet of A4 foil attached to a plastic frame, which was 3D printed in the early stages of the project but now ready for production in a regular plastic tool.

Additionally, the Poul Due Jensen Foundation (the Grundfos Foundation) has pledged £25 million to support research into COVID-19.